Vaccine vial stopper performance for fractional dose delivery of vaccines

Hum Vaccin Immunother. 2017 Jul 3;13(7):1666-1668. doi: 10.1080/21645515.2017.1301336. Epub 2017 May 2.

Abstract

Shortages of vaccines such as inactivated poliovirus and yellow fever vaccines have been addressed by administering reduced-or fractional-doses, as recommended by the World Health Organization Strategic Advisory Group of Experts on Immunization, to expand population coverage in countries at risk. We evaluated 3 kinds of vaccine vial stoppers to assess their performance after increased piercing from repeated withdrawal of doses needed when using fractional doses (0.1 mL) from presentations intended for full-dose (0.5 mL) delivery. Self-sealing capacity and fragmentation of the stopper were assessed via modified versions of international standard protocols. All stoppers maintained self-sealing capacity after 100 punctures. The damage to stoppers measured as the fragmentation rate was within the target of ≤ 10% of punctures resulting in a fragment after as many as 50 punctures. We concluded that stopper failure is not likely to be a concern if existing vaccine vials containing up to 10 regular doses are used up to 50 times for fractional dose delivery.

Keywords: fractional dosing; immunization; poliovirus; primary packaging; vaccine delivery; vial stoppers; yellow fever.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Drug Contamination / prevention & control*
  • Drug Packaging*
  • Humans
  • Poliovirus Vaccines / administration & dosage*

Substances

  • Poliovirus Vaccines